TransMedics Group, Inc. Made Headway
TransMedics Group, Inc. (TMDX:NASDAQ) jumped higher at $60.76, representing a gain of 51.2%. On Tue, Nov 07, 2023, TMDX:NASDAQ hit a New 2-Week High of $60.76. The stock got featured on our News Catalysts scanner on Mon, Nov 06, 2023 at 06:46 PM in the 'EARNINGS' category. From Tue, Oct 24, 2023, the stock recorded 50.00% Up Days and 45.45% Green Days
About TransMedics Group, Inc. (TMDX:NASDAQ)
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the OCS to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes the technology to replicate near-physiologic conditions for donor organs outside of the human body.
Top 10 Gainers:
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 250%
- Cardio Diagnostics Holdings Inc Com (CDIO:NASDAQ), 102.94%
- Senti Biosciences Inc Com (SNTI:NASDAQ), 78.08%
- Jaguar Global Growth Corporation I (JGGC:NASDAQ), 69.64%
- Vinco Ventures Inc. (BBIG:NASDAQ), 66.67%
- Tharimmune Inc Com (THAR:NASDAQ), 64.87%
- Korro Bio, Inc. (KRRO:NASDAQ), 60.81%
- TransMedics Group, Inc. (TMDX:NASDAQ), 51.18%
- PaxMedica Inc. (PXMD:NASDAQ), 47.54%
- Nuburu Inc. (BURU:NYSEMKT), 37.8%